Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BH1621 in Advanced Solid Tumors
CTR20260220Phase 2Active
- Sponsor
- Zhuhai Beihai Biotech
- Start
- Feb 2026
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of BH1621 in Nonhematologic neoplasms, sponsored by Zhuhai Beihai Biotech. Started Feb 2026; status: active.
02
Drugs
BH1621
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20260220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260220.